Correspondence 0001104659-23-042117 from Armata Pharmaceuticals, Inc. (ARMP)
Armata Pharmaceuticals, Inc.
Date: April 5, 2023 · CIK: 0000921114 · Accession: 0001104659-23-042117
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-269726
Letter
VIA EDGAR SUBMISSION Division of Corporation Finance Washington, DC 20549 Re: Armata Pharmaceuticals, Inc. (the “Company”) Registration Statement on Form S-3 (File No. 333-269726) (the “Registration Statement”)
Dear Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, the Company hereby requests that the U.S. Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on Thursday, April 6, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.
If you have any questions regarding this request, please contact our outside counsel, Naveen Pogula of Thompson Hine LLP, at (404) 541-2913 or Benjamin Russell of Thompson Hine LLP, at (404) 407-3609. Please also call either Naveen Pogula or Benjamin Russell as soon as the Company’s Registration Statement on Form S-3 has been declared effective. Thank you for your attention to this matter.
Sincerely,
ARMATA PHARMACEUTICALS, INC.
Show Raw Text
CORRESP
1
filename1.htm
ARMATA PHARMACEUTICALS,
INC.
4503 Glencoe Avenue
Marina del Rey, California
90292-3552
April 5, 2023
VIA EDGAR SUBMISSION
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Re:
Armata Pharmaceuticals, Inc. (the “Company”)
Registration Statement on Form S-3 (File No. 333-269726) (the “Registration
Statement”)
Dear Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act
of 1933, as amended, the Company hereby requests that the U.S. Securities and Exchange Commission take appropriate action to cause the
above-referenced Registration Statement on Form S-3 to become effective on Thursday, April 6, at 4:00 p.m., Eastern Time, or as soon thereafter
as is practicable.
If you have any questions regarding this request,
please contact our outside counsel, Naveen Pogula of Thompson Hine LLP, at (404) 541-2913 or Benjamin Russell of Thompson Hine LLP, at
(404) 407-3609. Please also call either Naveen Pogula or Benjamin Russell as soon as the Company’s Registration Statement on
Form S-3 has been declared effective. Thank you for your attention to this matter.
Sincerely,
ARMATA PHARMACEUTICALS, INC.
By:
/s/ Brian Varnum
Name: Brian Varnum
Title: Chief Executive Officer
cc: Naveen Pogula, Thompson Hine LLP
Benjamin Russell, Thompson
Hine LLP
Faith Charles, Thompson
Hine LLP